Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one
2. Geranyl-geranyl-acetone
3. Geranylgeranylacetone
4. Geranylgeranylacetone, (e,e,e)-isomer
5. Geranylgeranylacetone, (z,e,e)-isomer
6. Teprenon
7. Tetraprenyl Acetone
8. Tetraprenylacetone
1. Geranylgeranylacetone
2. Tetraprenylacetone
3. Selbex
4. 6809-52-5
5. 3796-63-2
6. Teprenona
7. Teprenonum
8. Teprenonum [inn-latin]
9. Teprenona [inn-spanish]
10. Unii-s8s8451a4o
11. (5e,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
12. 57b67oxm8f
13. 6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
14. 5,9,13,17-nonadecatetraen-2-one, 6,10,14,18-tetramethyl-, (e,e,e)-
15. E-0671
16. Geranylgeranyl Acetone
17. (5e,9e,13e)-6,10,14,18-tetramethyl-5,9,13,17-nonadecatetren-2-one
18. (5e,9e,13e)-teprenone
19. Teprenone [inn:jan]
20. Chebi:31649
21. Unii-57b67oxm8f
22. Selbelle
23. 5,9,13,17-nonadecatetraen-2-one, 6,10,14,18-tetramethyl-
24. 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one, Mixture Of (5e,9e,13e) And (5z,9e,13e) Isomers
25. Chembl79686
26. Schembl157509
27. Schembl157511
28. Dtxsid901166719
29. S8s8451a4o
30. Ea-0671
31. Bcp11723
32. Hy-b0779
33. Zinc1915509
34. Mfcd00869547
35. S5006
36. Akos015894922
37. (e,e,e)-geranylgeranyl Acetone
38. Ccg-267813
39. Cs-3560
40. E-671
41. 809t525
42. Sr-01000944917
43. Q-201789
44. Q7701388
45. Sr-01000944917-1
46. Teprenone [mixture Of (5e,9e,13e)- And (5z,9e,13e)- Isomers]
47. (5e,9e,13e)-6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one
48. (9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
49. 5,9,13,17-nonadecatetraen-2-one, 6,10,14,18-tetramethyl-, (5e,9e,13e)-
Molecular Weight | 330.5 g/mol |
---|---|
Molecular Formula | C23H38O |
XLogP3 | 7.4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 12 |
Exact Mass | 330.292265831 g/mol |
Monoisotopic Mass | 330.292265831 g/mol |
Topological Polar Surface Area | 17.1 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 482 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Teprenone acts as an anti-ulcer and gastric mucoprotective agent used to treat gastric ulcers and gastritis. Currently, the full mechanisms of action are still unclear.
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Teprenone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Teprenone, including repackagers and relabelers. The FDA regulates Teprenone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Teprenone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Teprenone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Teprenone supplier is an individual or a company that provides Teprenone active pharmaceutical ingredient (API) or Teprenone finished formulations upon request. The Teprenone suppliers may include Teprenone API manufacturers, exporters, distributors and traders.
click here to find a list of Teprenone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Teprenone Drug Master File in Japan (Teprenone JDMF) empowers Teprenone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Teprenone JDMF during the approval evaluation for pharmaceutical products. At the time of Teprenone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Teprenone suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Teprenone Drug Master File in Korea (Teprenone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Teprenone. The MFDS reviews the Teprenone KDMF as part of the drug registration process and uses the information provided in the Teprenone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Teprenone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Teprenone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Teprenone suppliers with KDMF on PharmaCompass.
Teprenone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Teprenone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Teprenone GMP manufacturer or Teprenone GMP API supplier for your needs.
A Teprenone CoA (Certificate of Analysis) is a formal document that attests to Teprenone's compliance with Teprenone specifications and serves as a tool for batch-level quality control.
Teprenone CoA mostly includes findings from lab analyses of a specific batch. For each Teprenone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Teprenone may be tested according to a variety of international standards, such as European Pharmacopoeia (Teprenone EP), Teprenone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Teprenone USP).
LOOKING FOR A SUPPLIER?